Hemodialysis and Peritoneal Dialysis Market – Potential Size

Description

Hemodialysis and Peritoneal Dialysis Market Synopsis

Hemodialysis and Peritoneal Dialysis Market Size Was Valued at USD 98673.51 Million in 2023 and is Projected to Reach USD 182938.8 Million by 2032, Growing at a CAGR of 7.1% From 2024-2032.

Kidney failure as the end stage of chronic kidney disease (CKD) is a serious health problem in which the kidneys can no longer work normally. Due to an increasing prevalence rate of type 2 diabetes, high blood pressure, and obesity, it is expected that by the year 2030, there will remarkably be an increase in people at risk of this deadly disease all over the world. 11% of the population worldwide is affected by diseases in which Hemodialysis and Peritoneal Dialysis have been considered as alternatives to their kidney function for survival. patients with end-stage renal disease (ESRD) undergoing HD experience a variety of stressors including drug side effects, dietary restrictions, functional limitations, changes in sexual function, psychological problems due to nearing death awareness, and social/family issues; all of which affect patient’s quality of life (QoL) and in some cases lead to depression and anxiety. Health-related QoL (HRQoL) is a more wide-ranging concept that encompasses multi-domains related to physical, psychological, emotional, and social functioning. Assessment of this measure can play an important role in setting goals for therapy, evaluating patient’s needs, monitoring disease progression and therapy efficacy, and improving patient care safely and with quality. It can also inform clinicians of the impacts of chronic diseases and other functional disabilities besides evaluating the effects of treatment interventions such as anemia correction or changes in dialysis treatment time or dialysis frequency.

Hemodialysis and Peritoneal Dialysis Market Trend Analysis

Emerging Trends in Dialysis Care: Home-Based Solutions and Technological Innovations

Because of its adaptability and independence, hemodialysis is becoming less and less preferred to peritoneal dialysis (PD). The shift to home dialysis, motivated by the advantages of freedom and higher survival rates, is a notable development in the dialysis business. Research has demonstrated that when compared to in-center treatments, home dialysis improves mortality rates. According to the American Society of Nephrology, individuals with end-stage kidney disease (ESKD) used home dialysis more frequently in 2021—up from 14.8% in 2016 to 20%. Similarly, a 3.4% rise in home hemodialysis (HHD) patients was reported in the UK Renal Registry’s 25th Annual Report between 2017 and 2021.

Governments are implementing new payment schemes, especially in the United States, to lower the cost of kidney disease treatments and increase the uptake of homecare dialysis. In order to improve patient care and outcomes, the industry is also seeing a surge in telemedicine and remote patient monitoring technologies.

Owing to technological developments, Automated Peritoneal Dialysis (APD) is becoming the preferred kind of PD. 50% of PD patients in Europe and 60% of patients in the United States chose APD by 2015. Propelled by technology improvements predicted to fuel significant growth from 2018 to 2025, the worldwide PD market is transitioning towards APD. Environmental sustainability is becoming more and more popular as service providers investigate eco-friendly methods and effective resource management.

Opportunity

Seizing Growth Opportunities: Dialysis Market Potential in Emerging Economies

In growing economies like China, India, and Brazil, the prevalence of diabetes and chronic kidney illnesses is rising, which is creating significant growth opportunities for the point-of-care (POC) diagnostics industry. Healthcare spending has increased in tandem with these countries’ economic growth, making hemodialysis and peritoneal dialysis more affordable for a greater proportion of the populace. Notably, programs like the Pradhan Mantri National Dialysis Programme in India are essential to democratizing access to dialysis services, especially for those from low-income backgrounds.

Market expansion is greatly aided by the spread of dialysis clinics in emerging nations and coordinated government initiatives to support healthcare infrastructure. These investments strengthen the healthcare ecosystem overall and improve access to dialysis treatments, creating a favorable climate for industry expansion.

A fertile environment for market actors to innovate is provided by the changing face of healthcare delivery, which is characterized by a move towards value-based models. There is an increasing need for technological solutions that enable remote monitoring, predictive analytics, and data-driven decision-making, as outcomes and quality of care are given precedence over traditional fee-for-service arrangements. This makes it possible for medical professionals to more accurately customize therapies, guaranteeing efficient and individualized care. To put it briefly, emerging countries are home to a growing number of patients as well as being a hub for collaboration and innovation. Market participants can take advantage of these trends to increase their market share and make a significant contribution to bettering healthcare outcomes globally.

Hemodialysis and Peritoneal Dialysis Market Segment Analysis:

Hemodialysis and Peritoneal Dialysis Market Segmented based on type, product, end-user, and region.

By Type, Hemodialysis Segment Is Expected To Dominate The Market During The Forecast Period

Healthcare professionals and patients with end-stage renal disease (ESRD) favor hemodialysis, which drives the market for hemodialysis and peritoneal dialysis. The most lucrative type of dialysis in 2023 was hemodialysis, which includes both nightly and traditional types (short daily and nocturnal). This trend is expected to continue. Key factors driving its demand include its clinical benefits, including shorter treatment times and the use of arteriovenous (AV) fistulas, as well as the rising rates of severe chronic kidney disease (CKD) among the elderly.

However, because of its effectiveness in eliminating harmful substances and the growing need for homecare options, peritoneal dialysis is anticipated to develop at the quickest rate of any market. The advantages of peritoneal treatment—such as cost-effectiveness, increased patient freedom, improved quality of life, and preservation of residual kidney function—are driving its adoption, even though it has received insufficient training in some places. Particularly in industrialized nations, the desire for peritoneal dialysis is expanding, bolstered by a rise in home dialysis utilization. For instance, among patients with end-stage kidney disease, home dialysis increased from 14.8% in 2016 to 20.0% in 2021, with peritoneal dialysis making up more than 90% of this treatment.

Because of its many patient benefits and the shift toward home-based treatment, peritoneal dialysis is therefore expected to experience significant growth, even if hemodialysis presently holds a dominant position in the market.

By End-user, Dialysis Centers & Hospitals Segment Held The Largest Share In 2023

Due to the majority of patients’ preference for obtaining treatment in clinics and dialysis centers, these facilities account for the greatest portion of the global market for hemodialysis and peritoneal dialysis services. The dialysis centers and hospitals segment is dominant due to various factors, including favorable reimbursements for renal therapies, an increase in the frequency of end-stage renal disease (ESRD) and chronic kidney disease (CKD), and rising healthcare expenditures. This sector is anticipated to continue leading the market during the forecast period, with the greatest market share in 2023.

For instance, six dialysis facilities in the Al Dhafra area of the United Arab Emirates improved their offerings in January 2023 by adding the newest medical technology and recruiting medical professionals with advanced training, increasing their ability to treat more patients and spurring market expansion. On the other hand, it is anticipated that the homecare industry would expand at the quickest rate, with a notable compound annual growth rate (CAGR) throughout the course of the forecast period. This increase is explained by the fact that homecare dialysis is a more affordable treatment option for end-stage kidney disease (ESKD), as well as the fact that dialysis patients are becoming more aware of and in need of home healthcare. Technological advancements in at-home dialysis are also driving this market.

To promote the expansion of homecare dialysis, Baxter, for example, introduced Sharesource Analytics 1.0 in June 2021. This next-generation digital health module is intended to improve the clinical management of patients receiving peritoneal dialysis (PD) at home. Thus, even though hospitals and dialysis facilities presently control the majority of the market, the homecare sector is expanding quickly because of its advantages from an economic and technological standpoint.

Hemodialysis and Peritoneal Dialysis Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast Period in 2023

Due to several important variables, North America is expected to lead the hemodialysis and peritoneal dialysis market. The area gains from a robust healthcare system, substantial medical payments, and an increasing uptake of home-based dialysis. Further driving market expansion is the rising prevalence of end-stage renal diseases (ESRD) and chronic kidney diseases (CKD), which are fueled by rising rates of obesity and diabetes. North America held a sizable 38.25% revenue share in the worldwide dialysis market in 2023, with high rates of CKD and ESRD therapy in the United States and Canada. This dominance is a result of government initiatives, sophisticated healthcare infrastructure, and large investments in cutting-edge medical technology.

The aging population in the area increases the need for dialysis since they are more likely to develop diabetes, hypertension, and chronic kidney disease. As an illustration, 38% of Americans 65 and older had CKD in 2021. According to the International Diabetes Federation, the number of cases of diabetes in the United States and Canada has significantly increased, which raises the risk of renal illnesses. Additionally, businesses’ attempts to create cutting-edge dialysis technology, such the pediatric dialysis machine from Medtronic and the portable hemodialysis system from Diality, support market expansion.

The strong market position of dialysis product makers in North America is reinforced by their strong regional presence and their relationships with renal care institutions. The increased need for dialysis services as a result of renal problems in infected patients is partly attributable to the COVID-19 pandemic. As a result, it is anticipated that the dialysis market in North America will continue to expand due to these several variables.

Hemodialysis and Peritoneal Dialysis Market Top Key Players:

Fresenius Medical Care (Germany)

Baxter International Inc. (USA)

DaVita Inc. (USA)

Nipro Corporation (Japan)

B. Braun Melsungen AG (Germany)

Asahi Kasei Corporation (Japan)

NxStage Medical, Inc. (USA)

Diaverum (Sweden)

Toray Medical Co., Ltd. (Japan)

Nikkiso Co., Ltd. (Japan)

Medtronic plc (Ireland)

JMS Co., Ltd. (Japan)

Mar Cor Purification (USA)

Rockwell Medical, Inc. (USA)

Outset Medical, Inc. (USA)

Fresenius Kabi (Germany)

Medline Industries, Inc. (USA)

Terumo Corporation (Japan)

Kawasumi Laboratories, Inc. (Japan)

Teleflex Incorporated (USA)

Atlantic Biomedical Company (USA)

Dialife SA, (Switzerland)

Bain Medical Equipment (Guangzhou) Co., Ltd. (China)

Chengdu OCI Medical Devices Co., Ltd. (China)

Fujian Kangda Medical Equipment Co., Ltd. (China)

Quanta Dialysis Technologies Ltd. (United Kingdom)

AWAK Technologies Pte Ltd (Singapore)

Infomed SA (Switzerland)

Atlantic Dialysis Management Services, LLC (USA)